← Leaderboards
Vahid Afshar-Kharghan
University Of Tx Md Anderson Can Ctr
$3,543,397
Attributed
$7,585,244
Total exposure
4
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.1M · FY2012–25$2M$1.5M$1M$500K$0
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$7,585,244 · 4
By mechanism
R01$7,162,594 · 3
R21$422,650 · 1
Top collaborators
- Anil K Sood13 shared
- Olga Gorlova5 shared
- Rahul Anil Sheth3 shared
- Qing Ma2 shared
Most similar at University Of Tx Md Anderson Can Ctr
Same institution · by research overlap
- Anil K Sood$29,572,737
- Tomasz Zal$2,840,316
- Scott Kopetz$13,199,822
- Erik Sulman$6,610,770
- Krishna Pl Bhat$3,427,143
Others in their field
Top investigators on “In Vitro”
- David Heimbrook · Leidos Biomedical Research, Inc.$553,787,942
- Leonard Freedman · Leidos Biomedical Research, Inc.$310,441,779
- Mark S Klempner · Tufts Medical Center$128,021,180
- Florian Krammer · Icahn School Of Medicine At Mount Sinai$104,723,856
- Lynn Briscoe · Leidos Biomedical Research, Inc.$94,686,873
- Dennis R. Burton · Scripps Research Institute$79,204,175
Research focus
In VitroAffectMouse ModelMalignant NeoplasmsBloodSamplingCancer CellOvarian NeoplasmReagentSpecimenBlood PlateletsMalignant Neoplasm Of OvaryCancer PatientProgramsTumorNeutrophilLiverResponseTissuesMediatingClinical DataIn VivoGrowthApplications Grants
Grant awards (20)
Novel Biomarkers Predicting Blood Clots in Ovarian Cancer$441,654
R01 · FY2025 · CA · contact PI
Novel Biomarkers Predicting Blood Clots in Ovarian Cancer$419,571
R01 · FY2024 · CA · contact PI
Novel Biomarkers Predicting Blood Clots in Ovarian Cancer$634,124
R01 · FY2023 · CA · contact PI
Platelets promote growth of ovarian cancer$479,382
R01 · FY2023 · CA · contact PI
Platelets promote growth of ovarian cancer$479,382
R01 · FY2022 · CA · contact PI
Genetics of Graft-versus-Host Disease$240,692
R01 · FY2022 · CA · contact PI
Platelets promote growth of ovarian cancer$489,165
R01 · FY2021 · CA · contact PI
Genetics of Graft-versus-Host Disease$281,522
R01 · FY2021 · CA · contact PI
Platelets promote growth of ovarian cancer$489,165
R01 · FY2020 · CA · contact PI
Genetics of Graft-versus-Host Disease$282,045
R01 · FY2020 · CA · contact PI
Genetics of Graft-versus-Host Disease$506,458
R01 · FY2019 · CA · contact PI
Platelets promote growth of ovarian cancer$504,165
R01 · FY2019 · CA · contact PI
Genetics of Graft-versus-Host Disease$265,229
R01 · FY2018 · CA · contact PI
Platelets promote growth of ovarian cancer$332,000
R01 · FY2017 · CA · contact PI
Platelets promote growth of ovarian cancer$332,000
R01 · FY2016 · CA · contact PI
Platelets promote growth of ovarian cancer$332,000
R01 · FY2015 · CA · contact PI
Platelets promote growth of ovarian cancer$322,040
R01 · FY2014 · CA · contact PI
Platelets promote growth of ovarian cancer$332,000
R01 · FY2013 · CA · contact PI
The role of complement system in alloimmune responses$185,650
R21 · FY2013 · AI
The role of complement system in alloimmune responses$237,000
R21 · FY2012 · AI